Metraipolis › archive › dc_e9ee916fdd9f
Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation,… — Europe PMC PMID:41648790
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41648790
- DOI
- 10.3389/fphys.2025.1752370
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T15:09:48.067Z
- SHA-256 of the archived text
fd51101e11d1e683ca47cda2e5e1463b84f041f6377890c9a3e41c55a26fb1d5- Stable URL of this page
https://metraipolis.com/documento/dc_e9ee916fdd9f
How to cite
Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation,… — Europe PMC PMID:41648790 — Europe PMC (en), https://europepmc.org/article/MED/41648790 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9ee916fdd9f (Metraipolis archive dc_e9ee916fdd9f, sha256 fd51101e11d1e683ca47cda2e5e1463b84f041f6377890c9a3e41c55a26fb1d5)
BibTeX
@misc{dce9ee916fdd9f,
title = {Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation,… — Europe PMC PMID:41648790},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41648790},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9ee916fdd9f; sha256 fd51101e11d1e683ca47cda2e5e1463b84f041f6377890c9a3e41c55a26fb1d5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41648790. Agents can read the archived copy with the MCP tool read_document.